Scaling Quality And Managing Cost Pressures Across CGTs

During Driving Efficiency, Reducing Costs in Multi-Modal CGT Manufacturing featuring expert panelists Steve Awad, Principal Director, Supply Chain & Industry X — Life Sciences, Accenture, and Michael Blackton, MBA, VP, Manufacturing and Supply at Ocugen examined how CGT developers can scale quality organizations without creating unsustainable overhead, while also addressing the distinct cost pressures of cell versus gene therapy manufacturing. Our experts emphasized that avoiding quality “bloat” starts with clearly defining roles, authority, and responsibilities across the company, aligning quality capabilities with mission-critical cycle times, and staffing to realistic throughput rather than theoretical capacity.